Published in Trends Cell Biol on August 01, 1993
Antiviral actions of interferons. Clin Microbiol Rev (2001) 13.06
Redundant and distinct functions for dynamin-1 and dynamin-2 isoforms. J Cell Biol (1998) 2.67
Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J Virol (1998) 2.26
Phragmoplastin, a dynamin-like protein associated with cell plate formation in plants. EMBO J (1996) 2.01
Interferon-induced human MxA GTPase blocks nuclear import of Thogoto virus nucleocapsids. Proc Natl Acad Sci U S A (1999) 1.78
Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein. J Virol (1996) 1.76
Human MxA protein inhibits tick-borne Thogoto virus but not Dhori virus. J Virol (1995) 1.73
Human MxA protein protects mice lacking a functional alpha/beta interferon system against La crosse virus and other lethal viral infections. J Virol (1999) 1.62
PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. EMBO J (2001) 1.47
Dominant-negative mutants of human MxA protein: domains in the carboxy-terminal moiety are important for oligomerization and antiviral activity. J Virol (1997) 1.44
Involvement of the Interleukin-23/Interleukin-17 Axis in Chronic Hepatitis C Virus Infection and Its Treatment Responses. Int J Mol Sci (2016) 1.39
Antivirally active MxA protein sequesters La Crosse virus nucleocapsid protein into perinuclear complexes. Proc Natl Acad Sci U S A (2002) 1.34
Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells. J Virol (1994) 1.34
Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells. J Virol (1999) 1.04
Cell proteins bind specifically to West Nile virus minus-strand 3' stem-loop RNA. J Virol (1996) 1.02
A monomeric GTPase-negative MxA mutant with antiviral activity. J Virol (2000) 1.01
Protection from lethal coxsackievirus-induced pancreatitis by expression of gamma interferon. J Virol (1999) 0.98
Role of nucleotide binding and GTPase domain dimerization in dynamin-like myxovirus resistance protein A for GTPase activation and antiviral activity. J Biol Chem (2015) 0.88
Quantification of different human alpha interferon subtypes and pegylated interferon activities by measuring MxA promoter activation. Antimicrob Agents Chemother (2005) 0.85
Hepatitis C virus infection suppresses the interferon response in the liver of the human hepatocyte chimeric mouse. PLoS One (2011) 0.84
Type I interferon dysregulation and neurological disease. Nat Rev Neurol (2015) 0.84
Pepscan mapping of viral hemorrhagic septicemia virus glycoprotein G major lineal determinants implicated in triggering host cell antiviral responses mediated by type I interferon. J Virol (2010) 0.81
Mx1-based resistance to thogoto virus in A2G mice is bypassed in tick-mediated virus delivery. J Virol (1998) 0.78
Bovine and water buffalo Mx2 genes: polymorphism and antiviral activity. Immunogenetics (2006) 0.78
The myxovirus resistance A (MxA) gene -88G>T single nucleotide polymorphism is associated with prostate cancer. Infect Genet Evol (2013) 0.77
Molecular cloning, polymorphism, and functional activity of the bovine and water buffalo Mx2 gene promoter region. Springerplus (2016) 0.75
Interferon-stimulated genes response in endothelial cells following Hantaan virus infection. J Korean Med Sci (2007) 0.75
Functional role of type I and type II interferons in antiviral defense. Science (1994) 18.92
Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J (1995) 6.94
Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. J Clin Invest (2001) 3.72
Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J Virol (2001) 3.65
cDNA structures and regulation of two interferon-induced human Mx proteins. Mol Cell Biol (1989) 3.20
Measles virus spread and pathogenesis in genetically modified mice. J Virol (1998) 2.84
A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J (1998) 2.48
The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur J Immunol (1995) 2.47
Induction of the PML protein by interferons in normal and APL cells. Leukemia (1995) 2.05
Inhibition of vesicular stomatitis virus mRNA synthesis by human MxA protein. J Virol (1991) 1.74
A functional GTP-binding motif is necessary for antiviral activity of Mx proteins. J Virol (1993) 1.64
Mechanism of human MxA protein action: variants with changed antiviral properties. EMBO J (1992) 1.63
Human MxA protein protects mice lacking a functional alpha/beta interferon system against La crosse virus and other lethal viral infections. J Virol (1999) 1.62
Neuroprotective and neurodegenerative effects of the chronic expression of tumor necrosis factor α in the nigrostriatal dopaminergic circuit of adult mice. Exp Neurol (2010) 1.60
Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins. J Virol (1998) 1.53
Lymphatic dissemination and comparative pathology of recombinant measles viruses in genetically modified mice. J Virol (2000) 1.48
A neuromodulatory role of interleukin-1beta in the hippocampus. Proc Natl Acad Sci U S A (1998) 1.47
Interleukin-6: a cytokine to forget. FASEB J (2004) 1.45
MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line. J Virol (1993) 1.43
[Infected myxoma as a cause of acute infective endocarditis]. Vnitr Lek (2010) 1.42
Overexpression of the influenza virus polymerase can titrate out inhibition by the murine Mx1 protein. J Virol (1992) 1.36
Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells. J Virol (1994) 1.34
Function of the mouse Mx1 protein is inhibited by overexpression of the PB2 protein of influenza virus. Virology (1993) 1.34
Roles of macrophages in measles virus infection of genetically modified mice. J Virol (2001) 1.33
Nuclear localization of mouse Mx1 protein is necessary for inhibition of influenza virus. J Virol (1992) 1.28
Mouse Mx2 protein inhibits vesicular stomatitis virus but not influenza virus. Virology (1992) 1.17
Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics. J Control Release (1999) 1.16
Expression of MxA protein in inflammatory dermatoses. J Histochem Cytochem (1995) 1.05
The first three years of the Swiss Neuropaediatric Stroke Registry (SNPSR): a population-based study of incidence, symptoms and risk factors. Neuropediatrics (2005) 1.04
cDNA cloning and mapping of the human creatine kinase M gene to 19q13. Am J Hum Genet (1987) 1.03
Mx proteins: GTPases involved in the interferon-induced antiviral state. Ciba Found Symp (1993) 1.01
Intramolecular backfolding of the carboxyl-terminal end of MxA protein is a prerequisite for its oligomerization. J Biol Chem (1999) 0.99
Mx genes show weaker primary response to virus than other interferon-regulated genes. Virology (1992) 0.96
DNA-based vaccine against La Crosse virus: protective immune response mediated by neutralizing antibodies and CD4+ T cells. Hum Gene Ther (1999) 0.87
Electronic estimations of renal function are inaccurate in solid-organ transplant recipients and can result in significant underdosing of prophylactic valganciclovir. Antimicrob Agents Chemother (2013) 0.86
Expression of the human MxA protein is associated with hyperphosphorylation of VSV P protein in human neural Cells. Virology (1996) 0.86
Hypersensitive sites in the 5' and 3' flanking regions of the cysteine proteinase I gene of Dictyostelium discoideum. Nucleic Acids Res (1986) 0.86
Enhanced protection against viral infection by co-administration of plasmid DNA coding for viral antigen and cytokines in mice. J Clin Virol (1999) 0.84
Viral factors influencing the outcome of human cytomegalovirus infection in liver transplant recipients. J Clin Virol (2011) 0.83
Knocking-down the NMDAR1 subunit in a limited amount of neurons in the rat hippocampus impairs learning. J Neurochem (2006) 0.81
IL-12 directly up-regulates the expression of HLA class I, HLA class II and ICAM-1 on human melanoma cells: a mechanism for its antitumor activity? Eur J Immunol (1999) 0.81
Interferon resistance of cutaneous T-cell lymphoma-derived clonal T-helper 2 cells allows selective viral replication. Blood (2001) 0.79
Immune stimulatory potential of B7.1 and B7.2 retrovirally transduced melanoma cells: suppression by interleukin 10. Br J Cancer (1998) 0.78
Signal transduction pathways involved in the expression of the uridine diphosphoglucose pyrophosphorylase gene of Dictyostelium discoideum. Dev Genet (1991) 0.78
Long-lasting anti-metastatic efficiency of interleukin 12-encoding plasmid DNA. Hum Gene Ther (1999) 0.77
Inhibition of human hematopoietic tumor formation by targeting a repressor Myb-KRAB to DNA. Cancer Gene Ther (2000) 0.77
Not all peripheral immune stimuli that activate the HPA axis induce proinflammatory cytokine gene expression in the hypothalamus. Ann N Y Acad Sci (2000) 0.77
Synergistic effect of a combined DNA and peptide vaccine against gp100 in a malignant melanoma mouse model. J Mol Med (Berl) (2001) 0.77
Induction of long-lasting cytokine effect by injection of IL-12 encoding plasmid DNA. Cancer Gene Ther (2000) 0.76
Induction of AP-1 binding to intron 1 of SP-A1 and SP-A2 is implicated in the phorbol ester inhibition of human SP-A promoter activity. Exp Lung Res (2000) 0.76
Mechanism of protection against influenza A virus by DNA vaccine encoding the hemagglutinin gene. Intervirology (2000) 0.76
Reduced melanoma tumor formation in mice immunized with DNA expressing the melanoma-specific antigen gp100/pmel17. Leukemia (1999) 0.75
[Hemodynamic effects and tolerance for trimepranol in acute myocardial infarct]. Vnitr Lek (1982) 0.75
[Intraventricular conduction disorders in infarction of the anterior wall and septum (author's transl)]. Cas Lek Cesk (1978) 0.75
[Perforation of the intraventricular septum complicating the course of acute myocardial infarct. Clinical, hemodynamic, and pathologico-anatomic picture]. Vnitr Lek (1979) 0.75
[Late hospital death in patients with myocardial infarction]. Vnitr Lek (1979) 0.75
[Effect of digitalis in the acute phase of myocardial infarct]. Vnitr Lek (1978) 0.75
[Ethical aspects of gene therapy]. Medicina (B Aires) (1998) 0.75
Abnormalities of atrioventricular conduction in patients with the Lown-Ganong-Levine syndrome. Cor Vasa (1978) 0.75
[Hypoxemia in acute myocardial infarction (author's transl)]. Cas Lek Cesk (1973) 0.75
Echocardiographically evaluated circulatory response to nitroglycerin. Acta Univ Carol Med (Praha) (1981) 0.75
[The incidence of splenomegaly in the Slovak population]. Vnitr Lek (1987) 0.75
A DNA vaccine against malignant melanoma coexpressing antigen and cytokine. Adv Exp Med Biol (1998) 0.75
Plasma tryptophan levels in the patients with cervicobrachial and lumbosacral pain syndromes. Adv Exp Med Biol (1996) 0.75
Assessment of myocardial infarct size in clinical practice. Cor Vasa (1979) 0.75
[Assessing the extent of myocardial infarction in clinical practice (author's transl)]. Cas Lek Cesk (1981) 0.75
[Vasodilation therapy of cardiac insufficiency in ischemic heart disease]. Cas Lek Cesk (1979) 0.75
[Hemodynamic diagnosis of complications in myocardial infarct]. Vnitr Lek (1978) 0.75
Trimepranol, a Czechoslovak-made beta blocker, in the treatment of acute myocardial infarction. Acta Univ Carol Med (Praha) (1984) 0.75
[Hemodynamic findings in the acute stage of myocardial infarct]. Cas Lek Cesk (1974) 0.75
Immunization with Naked DNA Coexpressing Antigen and Cytokine via IRES. Methods Mol Med (2000) 0.75
Hospital mortality in patients with acute myocardial infarction: five-year experience. Cor Vasa (1976) 0.75
[Advanced atrioventricular block in diaphragmatic wall infarction]. Cas Lek Cesk (1978) 0.75
Immune modulation in cancer using DNA inoculation--antitumour effect of interleukin-12. Dev Biol (Basel) (2000) 0.75
Myocardial rupture in acute myocardial infarction. Cor Vasa (1972) 0.75
Retroviral gene transfer of dominant negative raf-1 mutants suppresses ha-ras-induced transformation and delays tumor formation. Cancer Gene Ther (2000) 0.75
[Monitoring pulmonary artery pressure in clinical practice]. Vnitr Lek (1983) 0.75
[Blunt abdominal injuries with rupture of the diaphragm]. Monatsschr Unfallheilkd Versicher Versorg Verkehrsmed (1969) 0.75
[The fate of patients affected by some severe complication in the acute phase of a myocardial infarction (author's transl)]. Cas Lek Cesk (1973) 0.75
A comparison between cardiac pacing and exercise tests in patients with angina pectoris. Cor Vasa (1977) 0.75
[The programme and aims of secondary prevention of myocardial infarction. Present experiences in Prague 4 (author's transl)]. Cas Lek Cesk (1977) 0.75
[Hemodynamic observations in acute myocardial infarct]. Kardiologiia (1977) 0.75
Interleukin-10 inhibits the immune stimulatory potential of melanoma cells retrovirally transduced with human B7.1 or B7.2. Adv Exp Med Biol (1998) 0.75
Incidence of circulatory arrest in patients with acute myocardial infarction in coronary unit. Mechanism of their genesis and factors conditioning successful resuscitation. Cor Vasa (1978) 0.75